MedTrace Logo

Vitamin D3 Supplementation to Prevent Respiratory Tract Infections

NCT04596657 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 877

Last updated 2023-12-08

No results posted yet for this study

Summary

The Cooper vitamin D3 study is a randomized study investigating whether daily vitamin D3 supplementation can prevent respiratory tract infections, influenza-like illness and covid-19 in hospital workers.

Conditions

  • Respiratory Tract Infections
  • Covid19
  • Flu Like Illness

Interventions

DIETARY_SUPPLEMENT

Vitamin D supplementation

Daily vitamin D3 supplementation (5000 IU)

Sponsors & Collaborators

  • Won Sook Chung Foundation

    collaborator UNKNOWN

  • The Cooper Health System

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-27
Primary Completion
2021-11-23
Completion
2023-10-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04596657 on ClinicalTrials.gov